Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets

Bone regeneration (BR) is an ongoing challenge in biomedical research. While recombinant human bone morphogenetic protein-2 (rhBMP-2) is available for clinical use, its side effects remain a concern. Patient-derived platelet-rich plasma has been proposed as an alternative, but its heterogeneity poses a major hurdle to standardization. Here, we evaluated the effectiveness of induced pluripotent stem cell (iPSC)-derived megakaryocytes and platelets (iMPs) and recombinant human bone morphogenetic protein-2 (rhBMP-2) as potential BR therapy in a rat lumbar bone graft model. We implanted artificial bones with iMPs and/or rhBMP-2 and performed computed tomography and histological analysis to assess new bone formation. iMPs and rhBMP-2 showed comparable efficacy in vivo, but rhBMP-2 induced significant inflammation. In vitro, iMPs promoted human bone marrow mesenchymal stem cell (BM-MSC) proliferation and migration, while rhBMP-2 enhanced osteodifferentiation. RNA sequencing revealed cell cycle-related gene upregulation by iMPs. Altogether, these findings suggest iMPs, alone or in combination with rhBMP-2, as a promising BR therapy for enhancing clinical efficacy.

Authors

Institutions

Publication Details

Journal
Bone
Published
2025-11-05
DOI
https://doi.org/10.1016/j.bone.2025.117703
Primary Topic
Periodontal Regeneration and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets

Michiaki Mukai, Bahityar Rahmutulla, Seiji Ohtori, Sou Nakamura et al.
Bone
Periodontal Regeneration and Treatments
article

Bone morphogenetic protein-2-independent bone formation by human iPSC-derived megakaryocytes and platelets

Michiaki Mukai, Bahityar Rahmutulla, Seiji Ohtori, Sou Nakamura, Ikuko Tajiri, Miyako Suzuki‐Narita, Masaki Fukuyo, Koji Eto, Sumihisa Orita, Norichika Mizuki, Si Jing Chen, Susumu Tashiro, Kazuhide Inage, Kentaro Kosaka, Sudip Kumar Paul, Takahito Arai, Yasuhiro Shiga, Yawara Eguchi, Atsushi Kaneda, Masashi Sato, Naoya Takayama
article en

Abstract

Bone regeneration (BR) is an ongoing challenge in biomedical research. While recombinant human bone morphogenetic protein-2 (rhBMP-2) is available for clinical use, its side effects remain a concern. Patient-derived platelet-rich plasma has been proposed as an alternative, but its heterogeneity poses a major hurdle to standardization. Here, we evaluated the effectiveness of induced pluripotent stem cell (iPSC)-derived megakaryocytes and platelets (iMPs) and recombinant human bone morphogenetic protein-2 (rhBMP-2) as potential BR therapy in a rat lumbar bone graft model. We implanted artificial bones with iMPs and/or rhBMP-2 and performed computed tomography and histological analysis to assess new bone formation. iMPs and rhBMP-2 showed comparable efficacy in vivo, but rhBMP-2 induced significant inflammation. In vitro, iMPs promoted human bone marrow mesenchymal stem cell (BM-MSC) proliferation and migration, while rhBMP-2 enhanced osteodifferentiation. RNA sequencing revealed cell cycle-related gene upregulation by iMPs. Altogether, these findings suggest iMPs, alone or in combination with rhBMP-2, as a promising BR therapy for enhancing clinical efficacy.

BoneVol. 203
Chiba University (JP), Kyoto University (JP), Teikyo University Chiba Medical Center (JP)
Openalex Percentile: Top 55%
Periodontal Regeneration and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.